Code: MICR 302 Credits: 10
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR1 |
a) Remember the main components of bacterial cells (cell wall, membrane, genetic material) and their functions. b) Understand the differences between Gram-positive and Gram-negative bacteria and the significance of Gram staining. c) Apply the classification techniques for bacterial identification based on shape, metabolism, and genetic material. Clinical Benefits: Accurate bacterial identification is crucial for diagnosing infections and determining the best treatment options. Understanding Gram staining and classification helps in rapid diagnosis and effective treatment strategies, especially in emergency situations. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR2 |
a) Remember the essential nutritional requirements of bacteria, such as carbon, nitrogen, and minerals. b) Understand how bacteria adapt to various media in laboratory conditions. c) Evaluate the suitability of different culture media for specific bacterial species in clinical settings. Clinical Benefits: Helps in understanding how to grow and cultivate bacterial pathogens in a laboratory, ensuring accurate diagnostic testing. Knowledge of bacterial nutrition can assist in identifying the optimal growth conditions for clinical testing. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR3 |
a) Understand the phases of bacterial growth: lag, log, stationary, and death, and the factors that affect them. b) Analyze the implications of growth patterns in relation to bacterial infection progress. c) Apply knowledge of bacterial growth kinetics to predict treatment outcomes and antibiotic effectiveness. Clinical Benefits: Understanding bacterial growth helps predict infection progression and adjust treatment accordingly. Provides insight into how bacteria develop resistance over time, which helps in refining therapy. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR4 |
a) Remember the basic techniques for cultivating bacteria in solid and liquid media. b) Understand the significance of anaerobic and aerobic conditions for bacterial growth. c) Apply appropriate culture methods to identify pathogens and assess their antibiotic resistance profiles. Clinical Benefits: Essential for isolation and identification of bacterial pathogens, ensuring accurate diagnosis and the correct treatment approach. Antibiotic sensitivity testing is key in treating infections effectively, particularly in resistant cases. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR5 |
a) Recall the structure and function of bacterial DNA, plasmids, and operons. b) Understand the processes of horizontal gene transfer in bacteria (transformation, conjugation, and transduction). c) Analyze the role of bacterial genetics in the development of virulence and antibiotic resistance. Clinical Benefits: Bacterial genetics knowledge helps understand resistance mechanisms, guiding more effective treatment strategies. Identifying genetic factors responsible for virulence aids in developing targeted therapies for infections. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR6 |
a) Remember the mechanisms of action of common antibiotic classes (e.g., beta-lactams, tetracyclines). b) Understand the factors that influence antibiotic selection, including the pathogen’s resistance patterns. c) Apply the appropriate antibiotic therapy based on the susceptibility patterns of pathogens in clinical cases. Clinical Benefits: Choosing the right antibiotic based on the infection type and pathogen susceptibility reduces treatment failure. Knowledge of antibiotic mechanisms allows for tailored therapies, improving clinical outcomes and minimizing resistance development. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR7 |
a) Understand the mechanisms through which bacteria develop resistance to antibiotics (e.g., mutations, efflux pumps). b) Analyze the impact of antibiotic misuse on the development of resistance in clinical settings. c) Evaluate the role of antibiotic stewardship programs in preventing resistance. Clinical Benefits: Preventing antibiotic resistance ensures that treatments remain effective over time, particularly for serious infections. Knowledge of resistance mechanisms helps in choosing alternative antibiotics and optimizing treatment regimens to combat resistant infections. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR8 |
a) Remember the key virulence factors of bacteria (e.g., toxins, adhesion molecules). b) Understand how bacteria invade and evade host immune responses. c) Analyze the relationship between virulence factors and the severity of bacterial infections. Clinical Benefits: Understanding bacterial pathogenicity helps in developing preventive measures and targeted therapies to combat infections. Knowledge of virulence factors aids in designing vaccines and other therapeutic interventions. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR9 |
a) Recall the types of bacteria that make up the normal human flora. b) Understand how disturbances in normal flora can lead to opportunistic infections. c) Evaluate the role of probiotics and prebiotics in maintaining a healthy microbiome. Clinical Benefits: Understanding normal flora helps in avoiding unnecessary antibiotic use, which can disrupt the microbiome. Knowledge of flora disturbances guides the treatment of infections like Clostridium difficile associated with antibiotics. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR10 |
a) Remember the species of Staphylococcus responsible for common infections (e.g., Staphylococcus aureus). b) Understand the clinical presentations of Staphylococcus infections. c) Apply knowledge of Staphylococcus pathogenesis in the diagnosis and management of infections. Clinical Benefits: Timely diagnosis of Staphylococcal infections is crucial for preventing serious conditions like sepsis and endocarditis. Identifying resistance patterns helps guide appropriate treatment, especially in hospital-acquired infections. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR11 |
a) Recall the clinical signs and symptoms of Staphylococcus infections, such as skin abscesses and pneumonia. b) Understand the role of antibiotic resistance in the treatment of Staphylococcus infections. c) Analyze the factors contributing to Staphylococcus infection outbreaks in hospital settings. Clinical Benefits: Understanding the clinical manifestations of Staphylococcal diseases improves the ability to diagnose and treat infections. Helps prevent nosocomial infections by implementing effective infection control measures. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR12 |
a) Remember the key species of Streptococcus (e.g., Streptococcus pyogenes). b) Understand the diseases caused by Streptococcus species, including their pathogenesis. c) Apply knowledge of Streptococcus infections to select the appropriate diagnostic and therapeutic strategies. Clinical Benefits: Rapid diagnosis of Streptococcal infections helps prevent complications like rheumatic fever and glomerulonephritis. Appropriate antibiotic therapy can prevent the spread of infection and reduce complications. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR13 |
a) Recall the complications associated with Streptococcus infections, such as rheumatic fever and glomerulonephritis. b) Understand the mechanisms behind post-streptococcal autoimmune diseases. c) Evaluate strategies for preventing and managing the sequelae of untreated Streptococcus infections. Clinical Benefits: Early treatment can prevent long-term complications of Streptococcus infections like rheumatic heart disease. Knowledge of autoimmune sequelae informs post-infection care and monitoring. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR14 |
a) Remember the key characteristics of Streptococcus pneumoniae. b) Understand the clinical features of pneumococcal diseases such as pneumonia and meningitis. c) Apply preventive measures, including vaccination, in managing pneumococcal infections. Clinical Benefits: Pneumococcal vaccines are essential in preventing infections in high-risk populations, such as children and the elderly. Early diagnosis and treatment of pneumococcal infections can reduce mortality and morbidity, especially in immunocompromised patients. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR15 |
a) Remember the diseases caused by Neisseria species, such as gonorrhea and meningococcal meningitis. b) Understand the pathogenesis and transmission of Neisseria gonorrhea and Neisseria meningitides. c) Apply the principles of diagnosis and treatment for Neisseria infections, including prophylaxis. Clinical Benefits: Timely diagnosis of gonorrhea and meningococcal meningitis helps to reduce transmission and improve patient outcomes. Prophylactic treatment and vaccination strategies prevent the spread of these infections, particularly in high-risk populations. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR16 |
a) Remember the key characteristics of Corynebacterium diphtheria, including its morphology and toxin production. b) Understand the pathogenesis of diphtheria, including the role of diphtheria toxin in tissue damage. c) Apply knowledge of Corynebacterium diphtheria for diagnostic techniques and appropriate treatment strategies. Clinical Benefits: Early identification of diphtheria is critical for preventing severe complications like myocarditis and nerve damage. Vaccination against diphtheria provides effective prevention, especially in children and immunocompromised individuals. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR17 |
a) Recall the pathogenic characteristics of Listeria monocytogenes, including its intracellular survival and ability to cross barriers like the placenta and blood-brain barrier. b) Understand the clinical manifestations of listeriosis, particularly in vulnerable populations (e.g., pregnant women, neonates, immunocompromised). c) Evaluate treatment options for listeriosis, including the role of antibiotics in managing infection. Clinical Benefits: Early diagnosis of listeriosis allows for prompt antibiotic treatment, reducing the risk of complications such as neonatal sepsis and meningitis. Awareness of Listeria risk is essential for preventing infection, especially in pregnant women and immunocompromised individuals. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR18 |
a) Remember the characteristics of Bacillus anthracis and its ability to form spores. b) Understand the pathogenic mechanisms of anthrax, including toxin production and spore germination. c) Apply knowledge of anthrax diagnosis and treatment, including the role of antibiotics and vaccines in prevention. Clinical Benefits: Recognizing anthrax symptoms early allows for early treatment and reduces mortality, especially in cases of inhalation anthrax. Vaccination and appropriate antibiotic treatment are key for preventing outbreaks, particularly in high-risk occupational settings. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR19 |
a) Remember the main species of Clostridium, such as Clostridium tetani, Clostridium botulinum, and Clostridium perfringens. b) Understand the diseases caused by Clostridium species, including tetanus, botulism, and gas gangrene. c) Analyze the clinical presentation and management of Clostridia infections, focusing on toxin production and treatment options. Clinical Benefits: Timely administration of antitoxins and antibiotics can save lives in cases of tetanus and botulism. Awareness of gas gangrene and its rapid progression is essential for early surgical intervention and antibiotic therapy to prevent tissue necrosis. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR20 |
a) Understand the clinical manifestations of Clostridial diseases such as botulism, tetanus, and gas gangrene. b) Evaluate the role of toxin production in the pathogenesis of these diseases. c) Apply knowledge of preventive measures, including vaccination and proper wound care, to reduce the risk of Clostridial infections. Clinical Benefits: Vaccination for tetanus and botulism prevents life-threatening complications, particularly in high-risk groups. Early recognition of gas gangrene and the use of broad-spectrum antibiotics can prevent sepsis and death. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR21 |
a) Recall the characteristics of Mycobacterium tuberculosis, Mycobacterium leprae, and other non-tuberculous mycobacteria. b) Understand the pathogenesis of tuberculosis and leprosy, including the immune response and chronicity of the diseases. c) Evaluate treatment strategies for mycobacterial infections, including the importance of long-term antibiotic therapy. Clinical Benefits: Timely diagnosis and appropriate treatment of tuberculosis can prevent transmission and drug resistance. Leprosy management requires early detection to avoid nerve damage and disability, with multidrug therapy providing a successful treatment option. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR22 |
a) Recall the pathophysiology of Mycobacterium tuberculosis and its ability to form granulomas in the lungs. b) Understand the clinical signs and diagnostic methods for tuberculosis, including chest X-ray and sputum culture. c) Apply the principles of multi-drug therapy (DOTS) in the treatment of tuberculosis. Clinical Benefits: Early diagnosis and proper treatment of tuberculosis prevent its spread in the community and reduce complications. Directly observed treatment (DOT) ensures adherence to therapy, reducing the emergence of drug-resistant tuberculosis. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR23 |
a) Remember the characteristics of Mycobacterium leprae and its impact on peripheral nerves and skin. b) Understand the pathogenesis of leprosy and the role of the immune system in disease progression. c) Analyze the treatment options for leprosy, including the use of multidrug therapy (MDT). Clinical Benefits: Early detection of leprosy allows for appropriate treatment to prevent nerve damage and disfigurement. Multidrug therapy (MDT) is highly effective in curing leprosy and preventing its spread. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR24 |
a) Recall the types of non-tuberculous mycobacteria (NTM) such as Mycobacterium avium and their environmental reservoirs. b) Understand the risk factors for infection with NTM, particularly in immunocompromised patients. c) Evaluate the treatment strategies for infections caused by non-tuberculous mycobacteria. Clinical Benefits: Early identification of NTM infections allows for tailored antimicrobial therapy, improving outcomes, especially in HIV/AIDS patients. Awareness of environmental exposure and immunocompromised status helps prevent infections in susceptible individuals. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR25 |
a) Remember the key components and functions of the immune system, including primary and secondary lymphoid organs. b) Understand the basic principles of innate and adaptive immunity and how they work together to protect the body from infections. c) Apply the concepts of immunology to real-life clinical situations, such as vaccination and infection control. Clinical Benefits: Understanding the immune system is essential for diagnosing and treating immune-related disorders and infectious diseases. Knowledge of the immune system is foundational for vaccine development and improving immunization strategies. Helps in understanding the immune response to infections, which guides treatment protocols in infectious diseases. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR26 |
a) Recall the main differences between innate and adaptive immunity, including their components (e.g., phagocytes vs. lymphocytes). b) Understand how both systems cooperate to provide defense against pathogens. c) Analyze the role of antigen-presenting cells (APCs) in linking innate and adaptive immunity. Clinical Benefits: Knowledge of innate and adaptive immunity helps in diagnosing autoimmune diseases, inflammatory conditions, and allergic reactions. Understanding how immune responses work is critical in designing immunotherapies for cancer and chronic infections. Provides insights into the importance of the immune response in vaccination and its role in immunological memory. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR27 |
a) Understand the roles of B cells and T cells in the immune response, including the formation of antibodies and cytotoxic activity. b) Analyze the processes of clonal selection and clonal expansion in both B and T lymphocytes. c) Evaluate the importance of immune tolerance and its relationship to the function of B and T cells. Clinical Benefits: Key for diagnosing B and T cell deficiencies which can lead to immunodeficiencies such as SCID. Understanding B and T cell functions helps in the treatment of autoimmune diseases (e.g., Rheumatoid Arthritis, Multiple Sclerosis) and immunotherapies. Cancer immunotherapies like CAR T-cell therapy depend on manipulating these cells for effective treatment of hematological malignancies. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR28 |
a) Understand how immune cells, such as macrophages, dendritic cells, T-helper cells, and cytotoxic T cells, cooperate during an immune response. b) Analyze the process of antigen presentation and the activation of T cells in both cellular and humoral immune responses. c) Evaluate the impact of defective cell cooperation on the development of autoimmune diseases and chronic infections. Clinical Benefits: Knowledge of cell cooperation is essential for understanding the pathophysiology of diseases such as HIV/AIDS, where T cell cooperation is impaired. Understanding cell interaction helps in immunotherapy development, such as enhancing T-cell responses against cancers. Key for managing immune suppression in patients after organ transplants. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR29 |
a) Recall the four types of hypersensitivity reactions (Type I, II, III, IV) and their underlying mechanisms. b) Understand the clinical manifestations of hypersensitivity reactions, such as anaphylaxis, autoimmune hemolytic anemia, and contact dermatitis. c) Apply knowledge of hypersensitivity to manage and treat allergic reactions and immune-mediated diseases. Clinical Benefits: Hypersensitivity management is essential for treating allergic reactions like anaphylaxis and rashes caused by contact allergens. Helps in diagnosing and managing autoimmune diseases and understanding the role of immune responses in conditions like rheumatoid arthritis and lupus. Immunotherapy and desensitization techniques can be applied to treat allergies by understanding the mechanisms behind Type I hypersensitivity. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR30 |
a) Understand the mechanisms that lead to the development of autoimmunity, including loss of immune tolerance. b) Analyze the role of genetic predisposition and environmental factors in triggering autoimmune diseases. c) Apply knowledge of autoimmunity to diagnose and manage common autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis. Clinical Benefits: Knowledge of autoimmunity is crucial for the early diagnosis and management of diseases like lupus, multiple sclerosis, and Graves' disease. Aids in personalized medicine, helping to tailor treatments for patients based on their specific autoimmune profile. Improves understanding of immune-modulating therapies and the development of biological treatments for autoimmune diseases. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR31 |
a) Recall common autoimmune diseases and their associated clinical features (e.g., Hashimoto’s thyroiditis, Rheumatoid arthritis, Type 1 diabetes). b) Understand how immune dysregulation leads to the destruction of self-tissues in autoimmune diseases. c) Evaluate treatment strategies, including immunosuppressive drugs, biologics, and plasmapheresis for autoimmune diseases. Clinical Benefits: Early recognition and treatment of autoimmune diseases can help in preventing long-term organ damage and improving patient outcomes. Helps in immunosuppressive therapy, which is crucial for preventing autoimmune flare-ups and managing organ transplant rejection. Provides a foundation for understanding biologic therapies that target specific immune pathways in diseases like rheumatoid arthritis and psoriasis. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR32 |
a) Understand the distinction between primary and secondary immunodeficiencies and their causes. b) Analyze the clinical manifestations of immune deficiencies, including recurrent infections and poor vaccine responses. c) Evaluate diagnostic methods and therapeutic strategies for immune deficiencies, such as gene therapy and immunoglobulin replacement therapy. Clinical Benefits: Early diagnosis of immune deficiencies allows for timely treatment, including antibiotics, immunoglobulin therapy, and bone marrow transplants. Knowledge of immunodeficiencies helps prevent and treat opportunistic infections, especially in HIV/AIDS and primary immunodeficiencies. Advances in gene therapy offer hope for curative treatments for conditions like SCID and other genetic immune defects. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR33 |
a) Understand the structure and function of different types of immunoglobulins (IgA, IgD, IgE, IgG, IgM). b) Analyze how immunoglobulins play a role in immune responses such as neutralization of pathogens, opsonization, and complement activation. c) Apply knowledge of immunoglobulin deficiencies to diagnose and manage conditions like X-linked agammaglobulinemia. Clinical Benefits: • Understanding immunoglobulins helps in diagnosing and managing antibody deficiencies like IgA deficiency and Selective IgM deficiency. • Key for the use of immunoglobulin therapy in treating immunodeficiencies, including primary immunodeficiencies and autoimmune diseases. • Helps in understanding vaccination responses, as certain immunoglobulins are crucial for long-term immunity. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR34 |
a) Recall the components of the complement system and how they contribute to immune defense. b) Understand the role of the complement system in inflammation, phagocytosis, and immune complex clearance. c) Analyze the clinical implications of complement system deficiencies in diseases like SLE and paroxysmal nocturnal hemoglobinuria. Clinical Benefits: • Knowledge of the complement system is vital for diagnosing and managing immune complex diseases like lupus. • Provides insights into complement deficiencies, which can increase susceptibility to infections. • Essential for understanding the mechanisms behind complement-mediated tissue damage in diseases like autoimmune vasculitis. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR35 |
a) Understand the mechanisms of immune tolerance, including central and peripheral tolerance. b) Analyze the relationship between immune tolerance and the development of autoimmunity. c) Evaluate the role of immune tolerance in organ transplantation and cancer immunotherapy. Clinical Benefits: • Organ Transplantation: Knowledge of immune tolerance is essential in preventing organ rejection following transplants. • Autoimmunity Prevention: Insights into immune tolerance mechanisms help in understanding how autoimmune diseases develop and how tolerance breakdown leads to disorders such as lupus or rheumatoid arthritis. • Cancer Immunotherapy: Understanding immune tolerance is key for improving cancer immunotherapy, as tumor cells can evade immune responses by exploiting tolerance mechanisms. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR36 |
a) Understand the basic principles of virology, including viral structures, replication mechanisms, and classification. b) Analyze the differences between DNA and RNA viruses, and their clinical implications. c) Evaluate the impact of virus classification on diagnosis and treatment strategies. Clinical Benefits: • Accurate viral classification helps in selecting diagnostic techniques and antiviral therapies. • Understanding viral replication is critical in developing antiviral treatments. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR37 |
a) Remember how viruses are classified based on their genetic material (DNA/RNA), shape, and replication strategy. b) Understand the role of viral structure in host cell invasion. c) Analyze how viral classification impacts treatment options and prevention strategies. Clinical Benefits: • Viral classification aids in choosing the correct diagnostic test and tailoring treatment strategies. • Helps identify emerging viral threats and determine appropriate vaccines. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR38 |
a) Study the process of viral replication within the host cell. b) Understand the significance of viral attachment, entry, replication, and release. c) Apply knowledge of viral replication to the development of antiviral therapies. Clinical Benefits: • Understanding viral replication is essential for developing antiviral drugs that target specific steps in the replication process. • Knowledge of how viruses spread helps in controlling outbreaks and preventing infections. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR38 |
a) Understand the methods used to cultivate viruses in laboratory settings. b) Analyze the importance of cultivating viruses for diagnostic and research purposes. c) Evaluate how viral cultivation can impact the development of vaccines and therapies. Clinical Benefits: • Virus cultivation is critical for diagnosis and development of vaccines and antiviral drugs. • Helps isolate novel viruses, which is important for emerging viral infections and pandemic preparedness. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR39 |
a) Recall the characteristics of influenza viruses and their subtypes. b) Understand the pathogenesis and transmission dynamics of influenza. c) Evaluate the clinical implications of flu vaccines and antiviral treatments. Clinical Benefits: • Influenza vaccines are key in preventing outbreaks and protecting vulnerable populations, such as the elderly and immunocompromised individuals. • Antiviral treatments help reduce the severity and duration of symptoms, particularly in high-risk groups. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR40 |
a) Identify the different types of herpesviruses and the diseases they cause. b) Analyze the replication cycle of herpesviruses, including latency and reactivation. c) Evaluate the clinical manifestations of herpesvirus infections and the available antiviral treatments. Clinical Benefits: • Diagnosis and Treatment: Understanding herpesvirus infections is essential for diagnosing conditions like oral herpes, genital herpes, and shingles. Early diagnosis allows for effective antiviral treatment, reducing morbidity. • Neonatal Infections: Herpes simplex virus can cause neonatal infections, potentially leading to life-threatening conditions such as encephalitis. Early diagnosis and treatment are critical to preventing severe complications. • Prevention and Vaccination: Knowledge of the varicella-zoster virus and its vaccine is key for preventing chickenpox and shingles, especially in at-risk populations like the elderly and immunocompromised patients. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR41 |
a) Describe the structure and replication cycle of the rabies virus. b) Understand the transmission mechanisms of rabies and the clinical symptoms in humans. c) Evaluate the available prophylactic and therapeutic interventions for rabies. Clinical Benefits: • Early Intervention: Knowledge of rabies transmission and symptoms helps healthcare professionals initiate post-exposure prophylaxis (PEP) promptly. • Public Health Awareness: Understanding rabies transmission in animals helps reduce the risk of human exposure, especially in endemic regions. Educating patients and communities about preventive measures can save lives. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR42 |
a) Identify the different types of arboviruses and coronaviruses, including Zika virus, Dengue, and SARS-CoV-2. b) Understand the transmission routes, pathogenesis, and clinical presentations of diseases caused by arboviruses and coronaviruses. c) Evaluate the role of public health interventions, vaccines, and antiviral treatments in controlling outbreaks of these viruses. Clinical Benefits: • Outbreak Management: Knowledge of arboviruses and coronaviruses is crucial for managing emergency outbreaks, such as the COVID-19 pandemic and Zika virus outbreaks, guiding effective public health responses. • Vaccine Administration:Understanding the mechanisms of vaccine development for coronaviruses (e.g., COVID-19 vaccines) and arboviruses helps students in advising patients about immunization schedules and post- vaccine care. • Symptom Recognition: Healthcare providers can recognize symptoms of infections like Dengue fever or COVID-19, leading to timely diagnosis, treatment, and preventive measures to minimize transmission. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR42 |
a) Distinguish between the different types of hepatitis viruses and their modes of transmission. b) Analyze the clinical manifestations and complications of chronic hepatitis infections, such as cirrhosis and liver cancer. c) Evaluate the current treatments and vaccination strategies for hepatitis infections. Clinical Benefits: • Diagnosis and Management: Knowledge of hepatitis viruses aids in diagnosing various hepatitis-related diseases and determining the appropriate antiviral therapy, reducing liver-related morbidity and mortality. • Prevention and Vaccination: Vaccination strategies for Hepatitis A and Hepatitis B are essential in preventing infection, particularly in high-risk groups such as healthcare workers and intravenous drug users. • Chronic Hepatitis Care: Understanding the chronic effects of hepatitis infections (e.g., Hepatitis C) enables early detection. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR43 |
a) Explain the structure and replication cycle of retroviruses, with a focus on HIV. b) Understand the mechanisms of HIV pathogenesis, including the acute phase and AIDS progression. c) Evaluate the available antiretroviral therapies and their role in managing HIV infections. Clinical Benefits: • HIV Diagnosis and Management: Understanding HIV pathogenesis helps in the early diagnosis of HIV infection and initiation of ART, improving quality of life and reducing transmission. • Prevention of Transmission: Knowledge of HIV transmission modes (sexual, vertical, etc.) aids in counseling patients on prevention strategies, such as safe sexual +ices and mother-to-child transmission prevention. • AIDS Complication Management:AIDS Complication Management: Clinicians can identify and manage opportunistic infections associated with HIV/AIDS, improving patient outcomes and reducing complications in immunocompromised individuals. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR44 |
a) Define viral pathogenicity and understand the factors that contribute to viral virulence, such as genetic variability and host interaction. b) Analyze how different viruses evade host immune responses through mechanisms like antigenic variation, latency, and immune suppression. c) Evaluate the impact of viral mutations on disease progression and treatment efficacy. Clinical Benefits: • Early Detection and Diagnosis: Understanding viral pathogenicity helps healthcare providers recognize early signs of infection, facilitating timely diagnosis and treatment. • Treatment Approaches: Knowledge of how viruses interact with the immune system aids in developing targeted antiviral therapies and immunotherapies. • Prevention Strategies: Insight into viral pathogenicity is critical for developing effective vaccines and public health strategies to prevent viral outbreaks and reduce transmission. |
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR 45 |
a) Describe the innate and adaptive immune responses to viral infections, including the roles of interferons, T-cells, and antibodies. b) Analyze how immunization and natural immunity protect against viral diseases. c) Evaluate the immune evasion strategies used by viruses and their impact on the effectiveness of vaccines and treatments. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR 46 |
a) Identify the key arboviruses responsible for hemorrhagic fever, such as Dengue, Ebola, Yellow Fever, and Zika virus. b) Understand the transmission cycle of arboviruses, focusing on vectors like mosquitoes, and the epidemiology of hemorrhagic fever outbreaks. c) Evaluate the clinical manifestations, complications, and management of hemorrhagic fever viruses. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR 47 |
a) Describe the structure and replication cycle of Parvovirus B19, the virus responsible for erythema infectiosum (fifth disease). b) Analyze the clinical manifestations and complications associated with parvovirus B19 infections, including fetal hydrops and aplastic anemia. c) Evaluate diagnostic approaches and management strategies for parvovirus B19 infections, particularly in immunocompromised patients and pregnant women. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR 1 |
a) Understand laboratory safety protocols and the correct use of equipment. b) Identify and follow the proper procedures for handling bacterial cultures and samples. c) Apply effective hygiene and safety measures to prevent contamination in the microbiology lab. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR 2 |
a) Identify different sterilization methods (e.g., autoclaving, filtration, chemical sterilization). b) Understand the principles and appropriate use of each sterilization method. c) Apply sterilization techniques to ensure the aseptic preparation of laboratory materials. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ & Practical |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR 3 |
a) Understand the ubiquity of bacteria in the environment and the human body. b) Learn methods for isolating bacteria from various surfaces and environments. c) Explore how bacteria can influence human health in both positive and negative ways. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR 4 |
a) Identify different types of culture media used in microbiology for bacterial growth. b) Understand the principles of bacterial staining (e.g., Gram stain, acid-fast stain). c) Apply appropriate media and staining techniques for bacterial identification. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR 5 |
a) Understand the principles of antibiotic susceptibility testing (e.g., disk diffusion method). b) Learn how to interpret results from antibiotic susceptibility tests. c) Apply knowledge of bacterial resistance to select appropriate antibiotics for treatment. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR 6 |
a) Learn how to perform and interpret antibiotic susceptibility tests and bacterial motility tests. b) Understand how bacterial motility can influence infection and treatment outcomes. c) Analyze the correlation between motility and bacterial pathogenicity. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR 7 |
a) Learn the techniques for isolating and cultivating Staphylococcus aureus. b) Understand the growth requirements and characteristics of Staphylococcus aureus. c) Identify different types of Staphylococcus aureus through colony morphology and biochemical tests. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR 8 |
a) Understand the principle of the coagulase test and its role in identifying Staphylococcus aureus. b) Learn the technique for performing the coagulase test in a microbiology laboratory. c) Interpret the results of the coagulase test for diagnostic purposes. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR 9 |
a) Learn how to isolate and cultivate Streptococcus pyogenes from clinical samples. b) Understand the culture requirements for optimal growth of Streptococcus pyogenes. c) Identify Streptococcus pyogenes through characteristic growth patterns and biochemical reactions. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR 10 |
a) Learn the capsule staining technique for identifying Streptococcus pneumoniae. b) Understand the role of the capsule in bacterial virulence and pathogenesis. c) Apply capsule staining in the diagnosis of pneumococcal infections. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR 11 |
a) Learn how to perform Gram staining and oxidase testing for Neisseria species. b) Understand the diagnostic importance of these tests in identifying Neisseria gonorrhoeae and Neisseria meningitidis. c) Apply the oxidase test to differentiate between Neisseria species and other Gram-negative bacteria. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR 12 |
a) Understand the principle and application of acid-fast staining for identifying Mycobacterium species. b) Learn the procedure for performing acid-fast staining in laboratory settings. c) Identify Mycobacterium tuberculosis and other Mycobacterium species based on staining characteristics. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR 13 |
a) Learn the techniques for isolating and identifying Clostridium tetani and Clostridium perfringens. b) Understand the clinical significance of these pathogens in tetanus and gas gangrene. c) Apply appropriate laboratory tests to diagnose infections caused by Clostridium species. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR 14 |
a) Understand the role of immunological principles in microbiological diagnostics. b) Learn how immune responses can be used to detect bacterial and viral infections. c) Apply immunological techniques in the laboratory for detecting antibodies and antigens. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR 15 |
a) Understand the principles behind the Widal test and the ABO blood group test. b) Learn how to perform and interpret the results of these immunological tests. c) Analyze the clinical significance of the Widal test in diagnosing typhoid fever and the ABO test for blood transfusions. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR 16 |
a) Understand the characteristics of Enterobacteriaceae family members, including their classification and pathogenicity. b) Learn how to culture and identify members of the Enterobacteriaceae family. c) Understand the diagnostic importance of differentiating between different Enterobacteriaceae species. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR 17 |
a) Learn how to cultivate and diagnose Escherichia coli and Klebsiella species from clinical samples. b) Understand the pathogenicity and diseases caused by E. coli and Klebsiella. c) Apply biochemical tests to differentiate between E. coli and Klebsiella species. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR 18 |
a) Study the microbiological characteristics of E. coli and Klebsiella species. b) Learn the mechanisms of virulence and resistance in E. coli and Klebsiella. c) Analyze the clinical presentation and diagnostic techniques for infections caused by these bacteria. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR 19 |
a) Learn the diagnostic methods for identifying Salmonella and Shigella species. b) Understand the diseases caused by Salmonella and Shigella, including typhoid fever and dysentery. c) Apply laboratory techniques to differentiate between Salmonella and Shigella infections. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
MICR 20 |
a) Understand the epidemiology and pathogenesis of Salmonella and Shigella species. b) Learn about the laboratory diagnostic tests used for Salmonella and Shigella. c) Interpret laboratory results to accurately diagnose infections caused by Salmonella and Shigella. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR 21 |
a) Learn the characteristics of Pseudomonas species, particularly Pseudomonas aeruginosa. b) Understand the diagnostic methods used to identify Pseudomonas species in clinical samples. c) Analyze the pathogenicity and virulence factors of Pseudomonas aeruginosa. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR 22 |
a) Learn the techniques for isolating and cultivating Staphylococcus aureus. b) Understand the growth requirements and characteristics of Staphylococcus aureus. c) Identify different types of Staphylococcus aureus through colony morphology and biochemical tests. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR 23 |
a) Understand the characteristics of Vibrio species and their role in waterborne infections. b) Learn the technique for isolating Vibrio species from sea water samples and clinical specimens. c) Understand the principles and application of Thiosulfate Citrate Bile Salts Sucrose (TCBS) agar in the identification of Vibrio species. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR 24 |
a) Learn the diagnostic methods for identifying Brucella species, including blood cultures and serological tests. b) Understand the principles behind laboratory diagnosis of brucellosis, including bacterial isolation and biochemical tests. c) Explore the clinical manifestations of brucellosis and the importance of early diagnosis. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR 25 |
a) Understand the microbiological characteristics and pathogenicity of Corynebacterium species, particularly Corynebacterium diphtheriae. b) Learn the laboratory techniques used to isolate and identify Corynebacterium species from clinical samples. c) Study the biochemical and cultural characteristics used to differentiate Corynebacterium species. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
MICR 26 |
a) Understand the principles and techniques used in the isolation and identification of fungal species in clinical microbiology. b) Learn to differentiate between pathogenic and non-pathogenic fungi using laboratory tests, such as fungal culture, microscopy, and biochemical assays. c) Apply proper staining techniques (e.g., KOH, India ink) and culturing methods to identify common fungi. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Code: PARS 304 Credits: 5
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 1 |
a) Identify and classify various medical protozoan parasites based on their morphological characteristics. b) Analyze the differences in structure and function among protozoal species. c) Compare the life cycles of different protozoa and their implications in disease transmission. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 2 |
a) Understand the pathophysiology of dysenteric amoebiasis and its clinical manifestations. b) Analyze laboratory diagnostic methods for detecting Entamoeba histolytica. c) Evaluate the therapeutic options for treating amoebiasis. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 3 |
a) Identify the causative agents of giardiasis and balantidiasis, understanding their lifecycle and transmission. b) Explore clinical symptoms and diagnostic methods for both diseases. c) Discuss treatment options and the prevention strategies for giardiasis and balantidiasis. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 4 |
a) Explain the lifecycle of Trichomonas vaginalis and its clinical significance. b) Identify diagnostic techniques for detecting trichomoniasis. c) Understand the pharmacological treatment and prevention of trichomoniasis. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 5 |
a) Understand the lifecycle and transmission of Toxoplasma gondii. b) Recognize the clinical manifestations of toxoplasmosis in both immunocompetent and immunocompromised individuals. c) Evaluate the diagnostic techniques and treatment protocols for toxoplasmosis. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 6 |
d) Analyze the lifecycle of Plasmodium species and their role in malaria transmission. e) Recognize clinical symptoms and diagnostic methods for malaria. f) Discuss the latest treatment protocols and preventive measures for malaria. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 7 |
a) Understand the biology and lifecycle of Leishmania parasites. b) Identify clinical signs of cutaneous, mucocutaneous, and visceral leishmaniasis. c) Analyze diagnostic and treatment options for leishmaniasis. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 8 |
a) Study the lifecycle and pathogenicity of Trypanosoma species. b) Identify clinical signs and diagnostic methods for both African and American trypanosomiasis. c) Evaluate the available therapeutic treatments and challenges in managing trypanosomiasis. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 9 |
a) Classify and identify various medical arthropods and their role in disease transmission. b) Understand the lifecycle and clinical presentation of scabies and myiasis. c) Evaluate treatment strategies and preventive measures for arthropod-borne diseases. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 10 |
a) Understand the classification and characteristics of medically significant fungi. b) Analyze the mechanisms of fungal pathogenesis and host interactions. c) Study the laboratory techniques used for diagnosing fungal infections. Clinical Benefits:
|
K | Large group lecture | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 11 |
a) Understand the pathophysiology and clinical presentation of systemic candidiasis. b) Discuss diagnostic methods and treatment strategies for systemic Candida infections. c) Explore preventive measures for at-risk populations. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 12 |
a) Classify and describe the clinical manifestations of skin mycoses. b) Understand the diagnostic methods used to identify superficial, dermato, and subcutaneous fungal infections. c) Evaluate treatment options for managing various types of skin mycoses. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 13 |
a) Analyze the pathogenesis of pulmonary and neuro mycoses caused by invasive fungi. b) Identify the diagnostic techniques used for detecting pulmonary and central nervous system fungal infections. c) Understand treatment options and the role of antifungal drugs in managing severe mycoses. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 14 |
a) Identify the causative agents of mucormycosis and their risk factors. b) Discuss the clinical features and diagnostic methods for mucormycosis. c) Understand treatment approaches, including surgical interventions and antifungal therapy. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 15 |
a) Understand the sources and types of mycotoxins produced by fungi. b) Analyze the clinical symptoms and effects of mycotoxin exposure. c) Discuss the preventive and treatment measures for mycotoxicosis. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 16 |
a) Understand the general characteristics, classification, and lifecycle of helminths. b) Discuss the clinical significance of helminth infections in human health. c) Identify the major diagnostic methods used to detect helminth infections. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 17 |
a) Classify and describe the morphology of major helminths affecting human health. b) Compare and contrast the different types of helminths (nematodes, cestodes, trematodes). c) Analyze the impact of helminth infections on human health. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 18 |
a) Identify the causative agents of enterobiasis and ascariasis and understand their lifecycle. b) Recognize the clinical features and diagnostic techniques for these infections. c) Discuss treatment options for intestinal nematode infections. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 19 |
a) Identify the causative agents of trichuriasis and trichinosis, and describe their life cycle and clinical impact. b) Understand diagnostic methods and therapeutic approaches for these infections. c) Discuss the epidemiology and preventive measures for trichuriasis and trichinosis. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 20 |
a) Describe the lifecycle of hookworms and their method of transmission. b) Understand the clinical manifestations of hookworm infections, including anemia and malnutrition. c) Analyze diagnostic methods and treatment options for hookworm infections. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 21 |
a) Identify the causative agents of strongyloidiasis and trichostrongyliosis. b) Understand the clinical signs, symptoms, and diagnostic approaches for these infections. c) Discuss treatment regimens and prevention strategies for strongyloidiasis and trichostrongyliosis. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 22 |
a) Understand the lifecycle and pathophysiology of filarial infections, including Wuchereria bancrofti. b) Identify clinical manifestations of filariasis, including lymphatic filariasis and elephantiasis. c) Discuss diagnostic methods and available treatments for filarial infections. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 23 |
a) Describe the lifecycle and pathogenesis of Onchocerca volvulus and Loa loa. b) Recognize the clinical signs of onchocerciasis (river blindness) and loiasis. c) Discuss diagnostic techniques and treatment options for these infections. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 24 |
a) Study the lifecycle of Dracunculus medinensis and its impact on human health. b) Identify the clinical features of dracunculiasis (Guinea worm disease). c) Discuss current diagnostic techniques and eradication efforts for dracunculiasis. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 25 |
a) Identify the lifecycle of Taenia solium and Taenia saginata and understand the clinical impact of taeniasis. b) Discuss diagnostic methods for detecting taeniasis, including stool examination and serology. c) Explore treatment options for taeniasis and associated complications such as cysticercosis. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 26 |
a) Understand the lifecycle and pathogenicity of Hymenolepis nana and Diphyllobothrium latum. b) Identify the clinical features and diagnostic techniques for these infections. c) Discuss the treatment options for both hymenolepiasis and diphyllobothriasis. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 27 |
a) Analyze the lifecycle of Echinococcus granulosus and its clinical presentation. b) Discuss the diagnostic methods for hydatid disease and the role of imaging in diagnosis. c) Explore treatment options for hydatid cysts, including surgery and drug therapy. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 28 |
a) Understand the lifecycle of Schistosoma species and their clinical manifestations. b) Recognize diagnostic methods for schistosomiasis, including serological tests and stool examination. c) Discuss the available treatments for schistosomiasis and its long-term effects on organ systems. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 29 |
a) Study the lifecycle and clinical impact of Fasciola hepatica and Fasciolopsis buski. b) Identify the clinical features of fascioliasis and fasciolopsiasis, including liver inflammation and intestinal obstruction. c) Discuss diagnostic techniques and treatment options for liver and intestinal flukes. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 30 |
a) Understand the lifecycle and pathogenesis of Paragonimus westermani. b) Recognize the clinical symptoms of pulmonary paragonimiasis and its diagnostic challenges. c) Discuss the available treatments and preventive measures for lung fluke infections. Clinical Benefits:
|
K | Large group lecture | MCQ & Short answer questions |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 1 |
a) Understand the fundamental concepts of parasitology and the significance of parasitic infections in human health. b) Identify different types of parasites and understand their life cycles. c) Apply the principles of parasitology to real-world clinical scenarios. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 2 |
a) Learn the different methods of sterilization used in parasitology laboratories. b) Understand the principles behind physical and chemical sterilization techniques. c) Apply appropriate sterilization methods to prevent contamination in laboratory settings. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 3 |
a) Learn the microscopic techniques for examining stool samples for intestinal protozoa. b) Identify and differentiate between the key intestinal protozoa based on their morphology. c) Understand the clinical significance of these protozoa and their diagnostic criteria. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 4 |
a) Learn how to collect and examine swab samples from different body sites for parasitic infections. b) Identify Trichomonas vaginalis in swab samples using microscopic techniques. c) Understand the diagnostic criteria for detecting Trichomonas vaginalis in clinical settings. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 5 |
a) Learn the techniques for blood sample collection and examination for blood-borne parasitic diseases. b) Understand how to identify Plasmodium spp. (malaria) and Wuchereria bancrofti (filariasis) under the microscope. c) Interpret blood film results for the diagnosis of malaria and filaria. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 6 |
a) Learn the process for collecting cerebrospinal fluid (CSF) and its examination for parasitic infections. b) Understand the clinical relevance of CSF examination in diagnosing central nervous system infections caused by parasites. c) Identify parasitic pathogens in CSF samples using appropriate diagnostic techniques. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 7 |
a) Understand the basic principles of medical mycology, including fungal classifications and their clinical significance. b) Learn the methods for collecting fungal specimens from clinical samples. c) Recognize the difference between superficial and systemic fungal infections. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 8 |
a) Learn the techniques for collecting skin, nail, and hair samples for fungal infections. b) Understand how to examine these samples microscopically for fungal elements. c) Identify and differentiate fungal pathogens responsible for dermatophyte infections. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 9 |
a) Learn the different types of stains and their application in fungal identification. b) Understand the importance of biopsy stains in diagnosing fungal infections. c) Apply various staining techniques to identify fungal structures in biopsy samples. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 10 |
a) Learn how to examine various clinical samples (sputum, stool, urine, CSF) for parasitic and fungal pathogens. b) Understand the microscopic features of common parasites and fungi in different body fluids. c) Develop competency in identifying a broad range of parasitic and fungal pathogens in clinical specimens. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 11 |
a) Learn the techniques for culturing fungal pathogens from clinical samples. b) Understand the principles of antimicrobial sensitivity testing for fungal infections. c) Interpret culture results and susceptibility patterns to guide treatment decisions. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 12 |
a) Learn the classification and morphological characteristics of intestinal nematodes. b) Understand the life cycles and transmission methods of common intestinal nematodes. c) Identify key diagnostic features of intestinal nematodes. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |
Number | Learning Objective | Domain K/S/A/C | Teaching Learning Methods | Assessment Methods |
---|---|---|---|---|
PARS 13 |
a) Learn how to prepare and examine blood films for detecting parasitic infections. b) Identify blood-borne parasites using blood smear techniques. c) Understand the significance of blood film examination in diagnosing diseases like malaria and filariasis. Clinical Benefits:
|
K/S/C | Small group Lab | MCQ |